1
Open
[.]
2
Close
[.]
3
Allotment
—
4
Listing
[.]
Issue Size
23,00,400 shares (agg. up to ₹[.] Cr)
Listing Date
[.]
✦ AI Insight
Restated Financials (₹ Cr.)
| Period Ended | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 44.87 | 28.81 | 27.80 | 28.62 |
| Total Income | 32.62 | 52.04 | 44.46 | 42.84 |
| Profit After Tax | 2.00 | 3.11 | 2.15 | 0.18 |
| EBITDA | 3.49 | 5.78 | 4.28 | 1.74 |
| NET Worth | 11.46 | 8.63 | 5.52 | 3.36 |
| Reserves and Surplus | 6.01 | 3.23 | 2.82 | 0.66 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Bio Medica Laboratories Ltd. | SME | ₹52.43 Cr | ₹139 | 13.03 | ₹115.80 | -16.69% | ₹138.70 (-0.18%) |
| Goldline Pharmaceutical Ltd. | SME | ₹11.61 Cr | ₹43 | 10.47 | ₹56.77 | +32.02% | ₹38.13 (-4.65%) |
| Speciality Medicines Ltd. | SME | ₹29.14 Cr | ₹124 | 9.27 | ₹125.90 | +1.53% | ₹185.00 (+0.00%) |
| Accretion Nutraveda Ltd. | SME | ₹24.77 Cr | ₹129 | 26.27 | ₹191.20 | +48.22% | ₹273.75 (+0.09%) |
| KRM Ayurveda Ltd. | SME | ₹77.49 Cr | ₹135 | 17.32 | ₹180.70 | +33.85% | ₹255.30 (+2.51%) |
| Curis Lifesciences Ltd. | SME | ₹27.52 Cr | ₹128 | 12.44 | ₹141.00 | +10.16% | ₹112.00 (+1.82%) |
| Aptus Pharma Ltd. | SME | ₹13.02 Cr | ₹70 | 11.29 | ₹84.84 | +21.20% | ₹254.50 (+1.13%) |
| Hexagon Nutrition Ltd. | Mainboard | ₹138.87 Cr | ₹45 | 22.69 | ₹53.19 | +18.20% | ₹65.51 (+1.93%) |
| Sai Parenteral's Ltd. | Mainboard | ₹408.79 Cr | ₹392 | 72.19 | ₹405.70 | +3.49% | ₹535.60 (-0.34%) |
| Corona Remedies Ltd. | Mainboard | ₹655.37 Cr | ₹1062 | 43.47 | ₹1,438.40 | +35.44% | ₹2,113.00 (+4.28%) |
| Rubicon Research Ltd. | Mainboard | ₹1,377.50 Cr | ₹485 | 55.75 | ₹628.20 | +29.53% | ₹1,520.20 (-0.78%) |
| Amanta Healthcare Ltd. | Mainboard | ₹126.00 Cr | ₹126 | 34.59 | ₹141.75 | +12.50% | ₹163.00 (-0.61%) |
| Anlon Healthcare Ltd. | Mainboard | ₹121.03 Cr | ₹91 | 17.67 | ₹91.73 | +0.80% | ₹15.01 (-0.40%) |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Towards the purchase of Plant & Machinery/Equipment | 6.02 |
| 2 | Funding the Working Capital Requirements | 7.00 |
| 3 | Funding Marketing and Promotional Activities | 3.00 |
| 4 | General Corporate Purposes | |
| Total | 16.02 |
About Sheetal Medicare Products IPO
Incorporated on 1997, Sheetal Medicare Products Limited is a healthcare and pharmaceutical manufacturing company. The company is primarily engaged in the manufacturing of ayurvedic, herbal, and medicinal products, falling under the broader pharmaceuticals and botanical products segment. Its product range includes herbal formulations such as oils, syrups, powders, tablets, and wellness products catering to health and personal care needs. Sheetal Medicare focuses on natural and traditional healthcare solutions, combining ayurvedic practices with manufacturing processes to serve domestic markets. The company operates from its manufacturing facility in Maharashtra and continues to remain active in the healthcare sector. Overall, Sheetal Medicare Products Limited is a small-to-mid scale herbal and pharmaceutical manufacturer focused on ayurvedic healthcare products in India. Competitive Strengths: Organizational stability along with management expertise Established manufacturing facility designed to serve multiple products range Quality assurance and accreditations Proposed Distribution Network with Urban Market Presence Manufacturing Facility capable of safely managing Mercury + Read M
Contact Details
Sheetal Medicare Products Ltd. AddressSurvey No: 59,Dakiwali, Post Chamla,Lohape Road, Tal. Wada, District PalgharPalghar, Maharashtra, 421312+91 97555 33306secretarial@sheetalherbal.comVisit Website